Elvira Isganaitis

Assistant Professor

Harvard Medical School

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

David Sánchez-Infantes

SPAIN

View details

Josep Jimenez-Chillaron

Associate Professor

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elvira Isganaitis

Research Interests

Explore related searches

Contact this professor

Articles (10)

Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial.

Milky ways: effects of maternal obesity on human milk composition and childhood obesity risk.

Increasing breast milk betaine modulates <i>Akkermansia</i> abundance in mammalian neonates and improves long-term metabolic health.

Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial.

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial.

Brown Fat-Activating Lipokine 12,13-diHOME in Human Milk Is Associated With Infant Adiposity.

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes.

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial.

Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607-615.

Randomized Controlled Trial of Mobile Closed-Loop Control.

Collaborators (2)

David Sánchez-Infantes

Josep Jimenez-Chillaron

Make your next move.